{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:57:50Z","timestamp":1768586270795,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s12350-019-01655-6","type":"journal-article","created":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T17:59:21Z","timestamp":1550685561000},"page":"511-518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Nuclear cardio-oncology: From its foundation to its future"],"prefix":"10.1016","volume":"27","author":[{"given":"Milan G.","family":"Kahanda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandy","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamieson M.","family":"Bourque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-019-01655-6_bib1","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1007\/s12350-019-01655-6_bib2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2","article-title":"A clinicopathologic analysis of adriamycin cardiotoxicity","volume":"32","author":"Lefrak","year":"1973","journal-title":"Cancer"},{"key":"10.1007\/s12350-019-01655-6_bib3","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/1097-0142(197704)39:4<1397::AID-CNCR2820390407>3.0.CO;2-U","article-title":"Adriamycin cardiomyopathy\u2014Risk factors","volume":"39","author":"Minow","year":"1977","journal-title":"Cancer"},{"key":"10.1007\/s12350-019-01655-6_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11936-014-0315-4","article-title":"Anthracycline-induced cardiotoxicity: A review of pathophysiology, diagnosis, and treatment","volume":"16","author":"Raj","year":"2014","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1007\/s12350-019-01655-6_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-125-1-199607010-00008","article-title":"Anthracycline-induced cardiotoxicity","volume":"125","author":"Shan","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1007\/s12350-019-01655-6_bib6","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/CIRCRESAHA.115.303633","article-title":"Cardio-oncology: An update on cardiotoxicity of cancer-related treatment","volume":"118","author":"Lenneman","year":"2016","journal-title":"Circ Res"},{"key":"10.1007\/s12350-019-01655-6_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/157340311799960681","article-title":"Management of chemotherapy induced cardiomyopathy","volume":"7","author":"Saidi","year":"2011","journal-title":"Curr Cardiol Rev"},{"key":"10.1007\/s12350-019-01655-6_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jnci\/djp440","article-title":"Cardiotoxicity of anticancer drugs: The need for cardio-oncology and cardio-oncological prevention","volume":"102","author":"Albini","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1007\/s12350-019-01655-6_bib9","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(18)30533-6","article-title":"Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis","volume":"391","author":"Moslehi","year":"2018","journal-title":"Lancet"},{"key":"10.1007\/s12350-019-01655-6_bib10","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJMra1100265","article-title":"Cardiovascular toxic effects of targeted cancer therapies","volume":"375","author":"Moslehi","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1007\/s12350-019-01655-6_bib11","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0002-9343(87)90212-9","article-title":"Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy","volume":"82","author":"Schwartz","year":"1987","journal-title":"Am J Med"},{"key":"10.1007\/s12350-019-01655-6_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MNM.0b013e328025ae04","article-title":"Trastuzumab-induced cardiac dysfunction","volume":"28","author":"Panjrath","year":"2007","journal-title":"Nucl Med Commun"},{"key":"10.1007\/s12350-019-01655-6_bib13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.bjc.6600037","article-title":"Clinical and economic impact of multiple gated acquisition scan monitoring during anthracycline therapy","volume":"86","author":"Shureiqi","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1007\/s12350-019-01655-6_bib14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/BF00395392","article-title":"Noninvasive methods for the early detection of doxorubicin-induced cardiomyopathy","volume":"106","author":"Lenzhofer","year":"1983","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1007\/s12350-019-01655-6_bib15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/annonc\/mdf132","article-title":"Functional monitoring of anthracycline cardiotoxicity: A prospective, blinded, long-term observational study of outcome in 120 patients","volume":"13","author":"Jensen","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1007\/s12350-019-01655-6_bib16","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/sj.bjc.6600346","article-title":"Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients","volume":"86","author":"Nousiainen","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1007\/s12350-019-01655-6_bib17","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: A report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"15","author":"Plana","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1007\/s12350-019-01655-6_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1470-2045(14)70409-7","article-title":"Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: A report from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"16","author":"Armenian","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1007\/s12350-019-01655-6_bib19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1200\/JOP.2016.018770","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline Summary","volume":"13","author":"Armenian","year":"2017","journal-title":"J Oncol Pract"},{"key":"10.1007\/s12350-019-01655-6_bib20","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/ERP-17-0013","article-title":"Cardio-oncology: What you need to know now for clinical practice and echocardiography","volume":"4","author":"Larsen","year":"2017","journal-title":"Echo Res Pract"},{"key":"10.1007\/s12350-019-01655-6_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pcad.2014.05.002","article-title":"Cardio-oncology: Role of echocardiography","volume":"57","author":"Villarraga","year":"2014","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1007\/s12350-019-01655-6_bib22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1159\/000227621","article-title":"Review of tests for monitoring doxorubicin-induced cardiomyopathy","volume":"53","author":"Ganz","year":"1996","journal-title":"Oncology"},{"key":"10.1007\/s12350-019-01655-6_bib23","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0002-9149(97)89179-5","article-title":"Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions","volume":"77","author":"van Royen","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1007\/s12350-019-01655-6_bib24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/MNM.0b013e328343ceb9","article-title":"Assessing adriamycin-induced early cardiotoxicity by estimating left ventricular ejection fraction using technetium-99m multiple-Gated acquisition scan and echocardiography","volume":"32","author":"Fatima","year":"2011","journal-title":"Nucl Med Commun"},{"key":"10.1007\/s12350-019-01655-6_bib25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jcmg.2010.03.003","article-title":"Weighing the risks and benefits of cardiac imaging with ionizing radiation","volume":"3","author":"Gerber","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-019-01655-6_bib26","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"key":"10.1007\/s12350-019-01655-6_bib27","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.jacc.2013.01.090","article-title":"Cardiac complications of thoracic irradiation","volume":"61","author":"Jaworski","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-019-01655-6_bib28","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/annonc\/mdu055","article-title":"Effort myocardial ischemia during chemotherapy with 5-fluorouracil: An underestimated risk","volume":"25","author":"Lestuzzi","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1007\/s12350-019-01655-6_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11886-017-0844-z","article-title":"Cardio-oncology: The nuclear option","volume":"19","author":"Alvarez","year":"2017","journal-title":"Curr Cardiol Rep"},{"key":"10.1007\/s12350-019-01655-6_bib30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/hrt.2008.149088","article-title":"Radiation induced heart disease: Systemic disorders in heart disease","volume":"95","author":"Heidenreich","year":"2009","journal-title":"Heart"},{"key":"10.1007\/s12350-019-01655-6_bib31","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.1542\/peds.2007-0575","article-title":"Monitoring for cardiovascular disease in survivors of childhood cancer: Report from the Cardiovascular Disease Task Force of the Children\u2019s Oncology Group","volume":"121","author":"Shankar","year":"2008","journal-title":"Pediatrics"},{"key":"10.1007\/s12350-019-01655-6_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120949","article-title":"Implementation of a cardiac PET stress program: Comparison of outcomes to the preceding SPECT era","volume":"3","author":"Knight","year":"2018","journal-title":"JCI Insight"},{"key":"10.1007\/s12350-019-01655-6_bib33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nuclcard.2005.12.004","article-title":"Diagnostic accuracy of rest\/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT","volume":"12","author":"Bateman","year":"2006","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01655-6_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11886-015-0682-9","article-title":"Coronary microvascular dysfunction, microvascular angina, and management","volume":"18","author":"Loffler","year":"2016","journal-title":"Curr Cardiol Rep"},{"key":"10.1007\/s12350-019-01655-6_bib35","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1161\/01.CIR.91.7.1944","article-title":"Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease","volume":"91","author":"Di Carli","year":"1995","journal-title":"Circulation"},{"key":"10.1007\/s12350-019-01655-6_bib36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jcmg.2014.12.008","article-title":"Coronary microvascular dysfunction, microvascular angina, and treatment strategies","volume":"8","author":"Marinescu","year":"2015","journal-title":"J Am Coll Cardiol Imaging"},{"key":"10.1007\/s12350-019-01655-6_bib37","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1536\/ihj.16-537","article-title":"Bevacizumab-related microvascular angina and its management with nicorandil","volume":"58","author":"Katoh","year":"2017","journal-title":"Int Heart J"},{"key":"10.1007\/s12350-019-01655-6_bib38","doi-asserted-by":"crossref","first-page":"187ra69","DOI":"10.1126\/scitranslmed.3005066","article-title":"Coronary microvascular pericytes are the cellular target of sunitinib malate-induced cardiotoxicity","volume":"5","author":"Chintalgattu","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1007\/s12350-019-01655-6_bib39","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.7150\/thno.19551","article-title":"Cardiac metabolic deregulation induced by the tyrosine kinase receptor inhibitor sunitinib is rescued by endothelin receptor antagonism","volume":"7","author":"Sourdon","year":"2017","journal-title":"Theranostics"},{"key":"10.1007\/s12350-019-01655-6_bib40","first-page":"1549","article-title":"Routine oncologic FDG PET\/CT may be useful for evaluation of cancer therapy-Induced cardiotoxicity","volume":"55","author":"Kim","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01655-6_bib41","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2967\/jnumed.117.191122","article-title":"Doxorubicin effect on myocardial metabolism as a prerequisite for subsequent development of cardiac toxicity: A translational 18f-FDG PET\/CT observation","volume":"58","author":"Bauckneht","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01655-6_bib42","first-page":"2175","article-title":"Anthracycline and trastuzumab-induced cardiotoxicity in breast cancer","volume":"22","author":"Nicolazzi","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1007\/s12350-019-01655-6_bib43","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","article-title":"Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: A systematic review","volume":"63","author":"Thavendiranathan","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-019-01655-6_bib44","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.jacc.2015.04.012","article-title":"Subclinical cardiotoxicity associated with cancer therapy","volume":"65","author":"Yeh","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-019-01655-6_bib45","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1253\/circj.CJ-12-0264","article-title":"Normal range of left ventricular 2-dimensional strain: Japanese ultrasound speckle tracking of the left ventricle (JUSTICE) study","volume":"76","author":"Takigiku","year":"2012","journal-title":"Circ J"},{"key":"10.1007\/s12350-019-01655-6_bib46","first-page":"1965","article-title":"Indium-111-Antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer","volume":"31","author":"Estorch","year":"1990","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01655-6_bib47","first-page":"2044","article-title":"Indium-111-Antimyosin and iodine-123-MIBG studies in early assessment of doxorubicin cardiotoxicity","volume":"36","author":"Carri\u00f3","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01655-6_bib48","first-page":"842","article-title":"Annexin V imaging of acute doxorubicin cardiotoxicity (apoptosis) in rats","volume":"45","author":"Bennink","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01655-6_bib49","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2310\/7290.2008.00015","article-title":"Detection of dose response in chronic doxorubicin-mediated cell death with cardiac Technetium 99m annexin V single-photon emission computed tomography","volume":"7","author":"Gabrielson","year":"2008","journal-title":"Mol Imaging"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12350-019-01655-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-019-01655-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123018251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123018251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-019-01655-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:07:24Z","timestamp":1761026844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123018251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1071358123018251"],"URL":"https:\/\/doi.org\/10.1007\/s12350-019-01655-6","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nuclear cardio-oncology: From its foundation to its future","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-019-01655-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}